William A Petttit - Net Worth and Insider Trading
William A Petttit Net Worth
The estimated net worth of William A Petttit is at least $17,870 dollars as of 2024-11-13. William A Petttit is the Sr. V-P, HR and Administration of Ligand Pharmaceuticals Inc and owns about 148 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $17,870. Details can be seen in William A Petttit's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William A Petttit has not made any transactions after 2006-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William A Petttit
William A Petttit Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William A Petttit owns 1 companies in total, including Ligand Pharmaceuticals Inc (LGND) .
Click here to see the complete history of William A Petttit’s form 4 insider trades.
Insider Ownership Summary of William A Petttit
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2006-12-15 | Sr. V-P & HR and Administration |
William A Petttit Latest Holdings Summary
William A Petttit currently owns a total of 1 stock. William A Petttit owns 148 shares of Ligand Pharmaceuticals Inc (LGND) as of December 15, 2006, with a value of $17,870.
Latest Holdings of William A Petttit
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2006-12-15 | 148 | 120.74 | 17,870 |
Holding Weightings of William A Petttit
William A Petttit Form 4 Trading Tracker
According to the SEC Form 4 filings, William A Petttit has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 5,000 shares on December 15, 2006, which brought William A Petttit around $337,500.
Insider Trading History of William A Petttit
- 1
William A Petttit Trading Performance
William A Petttit Ownership Network
Ownership Network List of William A Petttit
Ownership Network Relation of William A Petttit
William A Petttit Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
William A Petttit is the Sr. V-P & HR and Administration of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include CHIEF LEGAL OFFICER & Andrew Reardon , VP & Finance and CFO Matthew E Korenberg , and Chief Financial Officer Octavio Espinoza .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, William A Petttit made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 70,748 shares made by Matthew E Korenberg , a net sale of 14,708 shares made by Octavio Espinoza , and a net sale of 13,500 shares made by Andrew Reardon .
In summary, during the past 3 months, insiders sold 39,680 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 39,680 shares. During the past 18 months, 106,227 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 99,727 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
William A Petttit Mailing Address
Above is the net worth, insider trading, and ownership report for William A Petttit. You might contact William A Petttit via mailing address: C/o Ligand Pharmaceuticals Inc.,, 10275 Science Center Dr., San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
